Fineline Cube

Follow:
14455 Articles
R&D

Soaring Costs of Cynomolgus Monkeys Impact China’s Biologic Drug Development

CompanyDeals

Shanghai Henlius Partners with Organon for Global Biosimilar Commercialization

CompanyDrug

BeiGene’s Brukinsa Faces Three-Month FDA Approval Delay for CLL/SLL Indication

CompanyDrug

Junshi Biosciences Receives NMPA Approval for Fourth-Generation EGFR Inhibitor WJ13404

CompanyDrug

Innovent Biologics Receives BPOM Approval for Bevagen in Indonesia

CompanyDrug

Innovent Biologics’ IBI306 Accepted for Review by China’s NMPA for Hypercholesterolemia

Policy / Regulatory

NHSA Releases Draft Proposals for NRDL Annual Renewal Process

CompanyDrug

Clover Biopharmaceuticals Begins Phase III Trial for COVID-19 Booster SCB-2019

CompanyDrug

InventisBio’s KRAS G12C Inhibitor D-1553 Earns CDE Breakthrough Therapy Status

CompanyDrug

CANbridge Pharmaceuticals Presents Positive Phase I Data for CAN106 at EHA Congress

CompanyDrug

Zai Lab’s Repotrectinib Earns Two Breakthrough Therapy Designations in China for ROS1+ NSCLC

CompanyDeals

OnCusp Therapeutics Licenses Multitude’s CDH6 ADC for Global Development